CN Patent

CN119950530B — 一种包含他莫昔芬与人参皂苷的纳米乳及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2025-12-05 · 0y expired

What this patent protects

本发明涉及药物制剂技术领域，具体是一种包含他莫昔芬与人参皂苷的纳米乳及其制备方法。本发明通过将枸橼酸他莫昔芬、人参皂苷、三丁酸甘油酯、肉豆蔻酸异丙酯、西黄蓍胶、泊洛沙姆、丙三醇制备成纳米乳将，所制备得到的纳米乳具有较小的粒径、良好的稳定性，可显著提高溶解度，进一步提高纳米乳的靶向性和治疗效果。

USPTO Abstract

本发明涉及药物制剂技术领域，具体是一种包含他莫昔芬与人参皂苷的纳米乳及其制备方法。本发明通过将枸橼酸他莫昔芬、人参皂苷、三丁酸甘油酯、肉豆蔻酸异丙酯、西黄蓍胶、泊洛沙姆、丙三醇制备成纳米乳将，所制备得到的纳米乳具有较小的粒径、良好的稳定性，可显著提高溶解度，进一步提高纳米乳的靶向性和治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN119950530B
Jurisdiction
CN
Classification
—
Expires
2025-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.